Vanguard Personalized Indexing Management’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDS
VCM
VFT
AA
XT
Vanguard Personalized Indexing Management's MEDS Position: Q1 2026 in Review
Vanguard Personalized Indexing Management sold out of DataMeds AI, Inc. Common Stock (MEDS) in Q1 2026, closing a stake of 363 shares — an estimated $7.26K sold.
Vanguard Personalized Indexing Management first reported a position in MEDS in Q4 2025 and held it in 1 quarter. The position peaked at $7.26K in Q4 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.
- Vanguard Personalized Indexing Management reported no remaining DataMeds AI, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
- Vanguard Personalized Indexing Management sold 363 DataMeds AI, Inc. Common Stock shares in Q1 2026, an estimated $7.26K.
- Vanguard Personalized Indexing Management first reported a position in DataMeds AI, Inc. Common Stock in Q4 2025 and held it in 1 quarter.
- Vanguard Personalized Indexing Management's DataMeds AI, Inc. Common Stock position peaked at $7.26K in Q4 2025.
- 13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.
Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.